 | • レポートコード：MRC2103C117 • 出版社/出版日：Mordor Intelligence / 2021年2月25日 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料では、世界のオンライン薬局市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、医薬品種類別（処方薬、市販（OTC）薬）分析、製品別（スキンケア、歯科、風邪・インフルエンザ、ビタミン、減量、その他）分析、地域別分析、競争状況、市場機会/将来の見通しなどを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のオンライン薬局市場規模：医薬品種類別（処方薬、市販（OTC）薬） ・世界のオンライン薬局市場規模：製品別（スキンケア、歯科、風邪・インフルエンザ、ビタミン、減量、その他） ・世界のオンライン薬局市場規模：地域別 ・競争状況 ・市場機会/将来の見通し |
The E-Pharmacy market is valued at approximately USD 60,430.14 million in 2020 and is expected to witness a revenue of USD 136,160.27 million in 2026, with a CAGR of 13.84% over the forecast period.
The studied market is expected to witness a drastic growth over the COVID-19 pandemic. Owing to the lockdown and travel restrictions, along with the fear of getting infected with the SARS-CoV2 virus has led to an increased dependence on online pharmacies for the purchase of both Over-the-Counter and prescription drugs. Also, in-person doctor visits in being replaced by virtual-based teleconsultations, which results in the generation of digital prescriptions. Similarly, key players are coming up with various strategies to combat the present pandemic. For instance, in March 2020, CVS Health began to implement new measures to balance the demand for the off-label use of drugs that are used in the treatment of both COVID-19 and other chronic diseases. Additionally, as the trend of non-contact delivery has been in progress given the COVID-19 pandemic, the demand for E-pharmacy has increased over the current crisis.
The growth of the e-pharmacy market is attributed to a rise in the number of internet consumers, increased access to web-based and online services, and the rising implementation of e-prescriptions in hospitals and other healthcare services.
E-prescription is the electronic prescribing technology that allows healthcare professionals to go paperless, by sending prescriptions in the digital format, instead of handwritten prescriptions. Doctors are now preferring e-prescriptions, to allow patients to get easy access to medicine with the help of e-prescriptions. Countries, like the United Kingdom, are putting more effort into the implementation of e-prescription. The NHS hospitals in England are planning to go paperless by the year 2020. This may increase the demand for e-prescription technology, rapidly, in the future. The major advantage of e-prescription is that one can easily upload their e-prescription on the ePharmacy website and order medicine online, without any hurdle. Therefore, due to the increasing implementation of e-prescriptions, uploading the prescription online has become easy and less time-consuming. Thus, all the aforementioned factors are augmenting the growth of the market.
Key Market Trends
The Over-the-Counter Drugs Segment, under Drug Type, is Expected to Grow at the Fastest Rate, during the Forecast Period
The Over-the-Counter Drug segment is poised to witness lucrative growth over the forecast timeframe. Major industry trends such as Rx to OTC switch by pharmaceutical manufacturers, a growing tendency of people towards self-medication in developing regions, and cost-saving advantage to the customers are strongly driving the segmental growth.
The increasing patent expiration rates are resulting in switching from Rx to OTC by the companies as a counter-strategy. In Feb 2020, the US Food and Drug Administration converted three prescription drugs to Over-the-Counter drugs, which include GlaxoSmithKline’s Voltaren Arthritis Pain, Alcon’s Pataday Twice Daily Relief, and Once Daily Relief (olopatadine HCl ophthalmic solution/drops, 0.2%). This resulted in easy access to the mentioned drugs to the customers. Also, in the current COVID-19 pandemic, the e-pharmacy market, in particular for the OTC drugs has witnessed significant growth, as consumers are reluctant to visit clinics for minor ailments in fear of being infected by COVID-19.
Additionally, the economic benefits received from OTC drug usage is attributable to savings on drug cost and cost incurred on a clinical visit; as healthcare provider visits are required to obtain a prescription for Rx treatments. This factor significantly attributes verticle growth in emerging economies.
North America Holds the Largest Market Share of the E-pharmacy Market, and is Expected to Witness the Same Trend over the Forecast Period
North America accounts for the largest share of the studied market. This can be primarily attributed to more number of internet users and higher adoption of online services, which are expected to augment the growth of the market over the forecast period. Furthermore, USFDA is spreading awareness among people, about purchasing prescription medicine from online pharmacies, to avoid the circumstances of people falling prey to unbranded and harmful drugs. According to the American Association of Homeopathic Pharmacists (AAHP), in 2020, Coronavirus Aid Relief and Economic Security (CARES) Act (HR 748) have been incorporated in the United States, wherein the legislation encourages the consumer to adopt OTC products for self-treatable symptoms, as it reduces the spread to coronavirus.
Additionally, the growing prevalence of minor illnesses such as flu, fever, backache, cough, and cold surges the demand for OTC medications, and thus the dependence on online pharmacies increases to obtain these drugs. Additionally, the ease of obtaining the medicines from the comfort of home is expected to drive the E-pharmacy market in North America, especially the United States. Also, the high concentration of market players and the incorporation of advanced technologies by key players to improvise the experience of online medicine purchase by customers is expected to drive the growth of the studied market in North America. For instance, in Nov 2020, Amazon launched an online pharmacy service in the United States for both generic and Prescription Medications.
Competitive Landscape
The e-pharmacy market is moderately competitive with few players currently dominating the market. The key market players of the studied market comprise CVS Health Corporation, Albertsons Companies, Inc., ALTO, Axelia Solutions (Pharmeasy), among others. These players are adopting various marketing strategies to gain a higher share in the e-Pharmacy market and focusing on expanding their geographic presence, especially in developing regions that offer lucrative opportunities. For instance, in Dec 2020, Express Scripts Holdings introduced “Express Scripts Parachute Rx’’ that offers extensive discounts on prescription medicines, with an aim to offer medications at an affordable price during the COVID-19 situation.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Access to Web-based and Online Services
4.2.2 Rising Implementation of E-prescriptions in Hospitals and Other Healthcare Services
4.3 Market Restraints
4.3.1 Increasing Number of Illegal Online Pharmacies
4.3.2 Low Penetration in Rural Areas in Developing Countries
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Drug Type
5.1.1 Prescription Drugs
5.1.2 Over-the-Counter (OTC) Drugs
5.2 By Product Type
5.2.1 Skin Care
5.2.2 Dental
5.2.3 Cold and Flu
5.2.4 Vitamins
5.2.5 Weight Loss
5.2.6 Other Product Types
5.3 Geography
5.3.1 North America
5.3.1.1 United States (By Drug Type, and By Product Type)
5.3.1.2 Canada (By Drug Type, and By Product Type)
5.3.1.3 Mexico (By Drug Type, and By Product Type)
5.3.2 Europe
5.3.2.1 Germany (By Drug Type, and By Product Type)
5.3.2.2 United Kingdom (By Drug Type, and By Product Type)
5.3.2.3 France (By Drug Type, and By Product Type)
5.3.2.4 Italy (By Drug Type, and By Product Type)
5.3.2.5 Spain (By Drug Type, and By Product Type)
5.3.2.6 Rest of Europe (By Drug Type, and By Product Type)
5.3.3 Asia-Pacific
5.3.3.1 China (By Drug Type, and By Product Type)
5.3.3.2 Japan (By Drug Type, and By Product Type)
5.3.3.3 India (By Drug Type, and By Product Type)
5.3.3.4 Australia (By Drug Type, and By Product Type)
5.3.3.5 South Korea (By Drug Type, and By Product Type)
5.3.3.6 Rest of Asia-Pacific (By Drug Type, and By Product Type)
5.3.4 Middle East and Africa
5.3.4.1 GCC (By Drug Type, and By Product Type)
5.3.4.2 South Africa (By Drug Type, and By Product Type)
5.3.4.3 Rest of Middle East and Africa (By Drug Type, and By Product Type)
5.3.5 South America
5.3.5.1 Brazil (By Drug Type, and By Product Type)
5.3.5.2 Argentina (By Drug Type, and By Product Type)
5.3.5.3 Rest of South America (By Drug Type, and By Product Type)
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 CVS Health Corporation
6.1.2 Cigna Corporation (Express Scripts Holdings)
6.1.3 Giant Eagle Inc.
6.1.4 Optum Rx Inc.
6.1.5 Rowlands Pharmacy
6.1.6 The Kroger Co.
6.1.7 Walgreen Boots Alliance (Walgreen Co.)
6.1.8 Amazon.com Inc.
6.1.9 Albertsons Companies Inc.
6.1.10 Netmeds.com
6.1.11 Axelia Solutions (Pharmeasy)
7 MARKET OPPORTUNITIES AND FUTURE TRENDS